fluorodeoxyglucose f18 has been researched along with Cancer of the Retina in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Y; Liu, H; Liu, Y | 1 |
| Bagci, U; Jassel, IS; Karantanas, AH; Millo, C; Papadakis, GZ; Patronas, NJ; Sadowski, SM | 1 |
| Bakhshi, S; Kumar, R; Malhotra, A; Radhakrishnan, V | 1 |
| Celdran, M; Decatur, C; Feuer, W; Hernandez, E; Houston, SK; Lampidis, T; Lopez-Cavalcante, M; Murray, TG; Piña, Y; Shah, N | 1 |
| Boers, M; Comans, EF; Hoekstra, OS; Imhof, SM; Moll, AC; Schouten-van Meeteren, AY; van der Valk, P | 1 |
2 trial(s) available for fluorodeoxyglucose f18 and Cancer of the Retina
| Article | Year |
|---|---|
Role of PET/CT in staging and evaluation of treatment response after 3 cycles of chemotherapy in locally advanced retinoblastoma: a prospective study.
Topics: Antineoplastic Agents; Biological Transport; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Humans; Male; Multimodal Imaging; Neoadjuvant Therapy; Neoplasm Staging; Optic Nerve; Positron-Emission Tomography; Prospective Studies; Retinal Neoplasms; Retinoblastoma; Tomography, X-Ray Computed; Treatment Outcome | 2012 |
Fluorine-18 fluorodeoxyglucose positron emission tomography (PET) to detect vital retinoblastoma in the eye: preliminary experience.
Topics: Child, Preschool; Female; Fluorodeoxyglucose F18; Humans; Infant; Male; Middle Aged; Pilot Projects; Radiopharmaceuticals; Retinal Neoplasms; Retinoblastoma; Tomography, Emission-Computed | 2004 |
3 other study(ies) available for fluorodeoxyglucose f18 and Cancer of the Retina
| Article | Year |
|---|---|
Detection of Parotid Metastasis from Retinoblastoma by
Topics: Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retinal Neoplasms; Retinoblastoma | 2022 |
18F-FDG and 68Ga-DOTATATE PET/CT in von Hippel-Lindau Disease-Associated Retinal Hemangioblastoma.
Topics: Adult; Fluorodeoxyglucose F18; Gallium Radioisotopes; Hemangioblastoma; Humans; Magnetic Resonance Imaging; Male; Organometallic Compounds; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Receptors, Somatostatin; Retinal Neoplasms; von Hippel-Lindau Disease | 2017 |
Retinoblastoma treatment: utilization of the glycolytic inhibitor, 2-deoxy-2-fluoro-D-glucose (2-FG), to target the chemoresistant hypoxic regions in LH(BETA)T(AG) retinal tumors.
Topics: Animals; Fluorodeoxyglucose F18; Glycolysis; Hypoxia; Mice; Neoplasms, Experimental; Radiopharmaceuticals; Retinal Neoplasms; Retinoblastoma; Treatment Outcome; Tumor Burden | 2012 |